Degenerative diseases are often described as the slow erosion of cells and tissues—an inevitable drift toward dysfunction. But a growing body of evidence suggests a different framing: these conditions may arise not merely from damage, but from a misconfigured metabolic state. If so, the task before science is not only to repair, but to reprogram. The following ten questions aim to sharpen that pursuit. What is the true primary driver of degeneration? Are mitochondrial failures the root cause, or do they emerge downstream of inflammation, protein aggregation, or systemic metabolic imbalance? When does cellular energy failure become irreversible? Is there a definable threshold at which declining ATP production triggers a cascade from which cells cannot recover? Is mitochondrial dysfunction a breakdown or a reprogramming? Do cells passively accumulate damage, or do they actively shift metabolic strategies under stress? To what extent is metabolic rewiring reversible? Can altered pathways be restored to their original configuration, and if so, within what temporal window? Why are certain cell types more vulnerable than others? What makes neurons particularly susceptible compared to more regenerative tissues? Is oxidative stress a cause or a signal? Do reactive oxygen species initiate degeneration, or do they reflect an already compromised system attempting to adapt? Does disease arise from a mismatch in fuel utilization? Are cells failing because they cannot efficiently switch between glucose, fatty acids, and ketones? Where does network failure begin? Within the interconnected web of metabolic pathways, are there identifiable nodes whose disruption propagates systemic collapse? Is aging itself a stochastic process or a programmed trajectory? If degeneration follows a pattern, can it be redirected rather than merely slowed? Can the system be reset? Beyond localized interventions, is it possible to shift the entire metabolic state of an organism toward resilience? These questions do not promise immediate answers. But they redefine the problem: from isolated defects to dynamic systems, from static damage to adaptive—and potentially reversible—states. The future of treating degenerative disease may depend less on replacing what is lost, and more on restoring the conditions under which life sustains itself. If so, the challenge is not simply to fight decline, but to learn how to rewire the processes that make vitality possible in the first place.